XORTX board chairman Anthony Giovinazzo resigns

XORTX Therapeutics Inc. (NASDAQ: XRTX) announced that Anthony Giovinazzo has resigned from its board of directors, citing personal reasons and a desire to pursue other interests, according to a company press release.

Giovinazzo served as chairman of the board and participated in key board committees. No replacement was announced.

Allen Davidoff, co-CEO of XORTX, said, "XORTX management and the board of directors extends our heartfelt appreciation for Mr. Giovinazzo's efforts as chairman of the board during the past several years."

XORTX is a pharmaceutical company with several drug candidates in development targeting gout and kidney disease.

You May Also Be Interested In

• FOMC minutes from July 28-29th meeting
• Legence Corp (LGN) PT Raised to $130 at Tigress Financial Partners
• Marvel Biosciences extends private placement to Quebec investors